ARISE-HF是一项全球性、Ⅲ期、随机、安慰剂对照、双盲的临床试验,旨在评估一种选择性醛糖还原酶抑制剂AT-001对于治疗DbCM患者运动能力的有效性。共有691名符合入组标准的糖尿病心肌病(DbCM)患者被1:1随机分配到接受安慰剂组或AT-001...
XETR : Order Management Service is down: On-Exchange Trading in Partition 50 not possible, please check Newsboard for further information 9 products affected: 1COV, BEI, BNR, CBK, DTE, FRE, MTX, MUV...